Page last updated: 2024-08-23

tobramycin and acyclovir

tobramycin has been researched along with acyclovir in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Williams, RC1
Calis, KA; Eastlund, T; Kintzel, PE1
Montané Esteva, D; Núñez Pérez, J1
Hollmén, A; Huikko-Tarvainen, S; Kärjä, V; Naukkarinen, A; Pirinen, E; Sankilampi, U1
Li, W; Sun, X; Sun, Y; Wang, M; Xing, Q1

Reviews

1 review(s) available for tobramycin and acyclovir

ArticleYear
Extracorporeal removal of antimicrobials during plasmapheresis.
    Journal of clinical apheresis, 2003, Volume: 18, Issue:4

    Topics: Acyclovir; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clinical Trials as Topic; Humans; Plasma Exchange; Plasmapheresis; Tobramycin; Vancomycin

2003

Other Studies

10 other study(ies) available for tobramycin and acyclovir

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
The use of the PREP system for handling of body fluids.
    International journal of environmental analytical chemistry, 1984, Volume: 18, Issue:1-2

    Topics: Acyclovir; Anticonvulsants; Automation; Barbiturates; Benzodiazepines; Body Fluids; Brain Chemistry; Chromatography, High Pressure Liquid; Dronabinol; Humans; Ion Exchange; Liver; Polystyrenes; Resins, Plant; Silicon Dioxide; Specimen Handling; Tobramycin; Vanilmandelic Acid; Vinyl Compounds

1984
[Arcuate keratotomy to correct residual astigmatism after stromal herpetic keratitis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:3

    Topics: Acyclovir; Antiviral Agents; Astigmatism; Dexamethasone; Drug Therapy, Combination; Female; Humans; Keratitis, Herpetic; Lens Implantation, Intraocular; Middle Aged; Ophthalmologic Surgical Procedures; Phacoemulsification; Postoperative Complications; Tobramycin; Valacyclovir; Valine; Virus Activation

2004
Congenital Langerhans cell histiocytosis mimicking a "blueberry muffin baby".
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:3

    Topics: Acyclovir; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Infant; Injections, Intravenous; Male; Penicillin G; Predictive Value of Tests; Prognosis; Rare Diseases; Remission, Spontaneous; Skin Diseases; Tobramycin

2008
Clinical diagnosis and treatment of rare painless keratitis caused by three pathogens: clinical practice and experiential discussion.
    The Journal of international medical research, 2020, Volume: 48, Issue:1

    Topics: Acanthamoeba; Acyclovir; Administration, Ophthalmic; Adult; Anti-Bacterial Agents; Antiviral Agents; Female; Humans; Keratitis; Male; Simplexvirus; Staphylococcus epidermidis; Tobramycin

2020